SPEC — SpectraCure AB (publ) Cashflow Statement
0.000.00%
Last trade - 00:00- SEK34.82m
- SEK24.09m
- SEK0.87m
Annual cashflow statement for SpectraCure AB (publ), fiscal year end - December 31st, SEK millions except per share, conversion factor applied.
2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | 2025 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | PRESS |
| Standards: | IFRS | IFRS | IFRS | IFRS | — |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -23.3 | -25.4 | -20.4 | -23 | -56.1 |
| Non-Cash Items | 2.68 | 3 | 3.56 | 3.31 | 32 |
| Other Non-Cash Items | |||||
| Changes in Working Capital | 2.06 | -0.578 | -1.8 | -1.43 | 0.085 |
| Change in Accounts Receivable | |||||
| Change in Other Liabilities | |||||
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | -18.6 | -23 | -18.7 | -21.1 | -24 |
| Capital Expenditures | -8.49 | -10.1 | -15.8 | -15.3 | -19.6 |
| Purchase of Fixed Assets | |||||
| Purchase / Acquisition of Intangibles | |||||
| Other Investing Cash Flow Items | — | -1.23 | 0.205 | 0 | — |
| Sale of Fixed Assets | |||||
| Sale/Maturity of Investment | |||||
| Purchase of Investments | |||||
| Cash from Investing Activities | -8.49 | -11.3 | -15.6 | -15.3 | -19.6 |
| Financing Cash Flow Items | 1.8 | 0 | — | — | -13.5 |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | -0.453 | -2.2 | -1.99 | -2.28 | 38.9 |
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | -27.5 | -36.5 | -36.2 | -38.7 | -4.75 |